MaxCyte, Inc.MXCTNASDAQ
Loading
SG&A Expenses Over TimeContracting
Percentile Rank85
3Y CAGR+1.9%
5Y CAGR+24.5%
Studio
Year-over-Year Change

Selling, general, and administrative expenses

3Y CAGR
+1.9%/yr
vs +38.7%/yr prior
5Y CAGR
+24.5%/yr
Recent deceleration
Acceleration
-36.9pp
Decelerating
Percentile
P85
Within normal range
vs 5Y Ago
3x
Strong expansion
Streak
2 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$47.04M-16.5%
2024$56.35M-1.2%
2023$57.04M+28.2%
2022$44.48M+40.4%
2021$31.68M+101.8%
2020$15.70M+17.1%
2019$13.41M+11.7%
2018$12.01M+13.9%
2017$10.54M+17.2%
2016$8.99M-